Focused on clinical diagnostics, the company develops laboratory tests and biomarker-based technologies aimed at improving disease detection and monitoring. Its work centers on translating molecular and biochemical research into diagnostic assays that can be used in clinical and laboratory settings....
No congressional trades have been disclosed for NexEos Diagnostics, Inc (NEDI) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.